Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

NCT03487770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder

Interventions

DRUG: Aripiprazole Oral Solution
DRUG: Placebo Oral Solution

Sponsor

Otsuka Beijing Research Institute